Visfatin is a multifaceted molecule that exerts regulation effects on inflammation and apoptosis in RAW264.7 cells and mice immune organs

Zhewei Zhang, Ke Xiao, Sheng Wang, Abdur Rahman Ansari, Xiaoyu Niu, Wenjie Yang, Mengqi Lu, Zhi Yang, Zia Ur Rehman, Weihua Zou, Weicheng Bei, Hui SongFrontiers in Immunology 2022 · DOI

Abstract

Visfatin, a multifunctional adipocytokine, is particularly important in the regulation of apoptosis and inflammation through an unidentified mechanism. Clarifying the control mechanisms of visfatin on inflammation and apoptosis in RAW264.7 cells and mice immunological organs was the goal of the current investigation. In order to create a pathophysiological model, the RAW264.7 cells were stimulated with 200 ng/mL visfatin and 20 μg/mL lipopolysaccharide (LPS), either separately or combined. The effects of exogenous visfatin on inflammation and apoptosis in RAW264.7 cells were investigated by flow cytometry assay, RNA-seq analysis and fluorescence quantitative PCR. According to the findings, exogenous visfatin exhibits dual effects on inflammation by modulating the expression of IL-1α, TNFRSF1B, and LIF as well as taking part in various signaling pathways, including the MAPK and Rap1 signaling pathways. By controlling the expression levels of Bcl2l1, Bcl2a1a, and Fas and primarily participating in the PI3K/AKT signaling pathway and Hippo signaling pathway, exogenous visfatin can inhibit apoptosis in RAW264.7 cells. The visfatin inhibitor FK866 was used to further confirm the effects of visfatin on inflammation and apoptosis in mice immune organs. Subsequently, mice spleen and thymus were collected. It is interesting to note that in LPS-treated mice, suppression of endogenous visfatin might worsen the immune system's inflammatory response and even result in rapid mortality. Additionally, endogenous visfatin promotes the apoptosis in mice immune organs by regulating the expression levels of Bcl2l1, Fas, Caspase 3, Bcl2a1a, and Bax. Together, these results imply that visfatin is a multifaceted molecule that regulates inflammation and apoptosis in RAW264.7 cells and mice immunological organs by taking part in a variety of biological processes and regulating the amounts of associated cytokines expression. Our findings offer additional understandings of how visfatin affects apoptosis and inflammation.

Introduction

Visfatin, also known as NAMPT, has long been recognized for its role in energy metabolism and its presence in adipose tissue. However, its influence on the immune system—specifically how it regulates inflammation and programmed cell death (apoptosis)—has remained controversial. Researchers sought to clarify whether visfatin acts as a pro-inflammatory agent or a protective factor during immune crises. By using lipopolysaccharide (LPS) to simulate severe bacterial infection (sepsis) in both cell cultures and live mice, this study investigates how visfatin levels dictate the survival of immune cells and the health of immunological organs like the spleen and thymus.

Methods

The study employed a dual-track approach:

  • In Vitro (Cell Culture): Murine macrophage-like cells (RAW264.7) were treated with exogenous visfatin and LPS. The team used MTT assays for viability, flow cytometry to track apoptosis stages, and RNA-seq to map global transcriptomic shifts. Findings were validated using qRT-PCR for specific gene expressions (e.g., IL-1α, Fas, Bcl2l1).
  • In Vivo (Animal Model): Male Kunming mice were subjected to LPS-induced inflammation. To isolate the effect of visfatin, researchers used FK866, a specific chemical inhibitor that blocks visfatin's activity. They then performed histological analysis (HE staining and IHC) on the spleen and thymus and monitored survival rates.

Key Results and Insights

The study revealed that visfatin acts as a critical "double agent" in the immune system. While it can trigger inflammatory markers, it simultaneously acts as a vital survival factor.

Figure 5: Visfatin and LPS concentration screening and their effects on RAW264.7 cell apoptosis. (A-B) MTT assays showing optimal concentrations for cell viability. (C-D) Flow cytometry detection and quantification of apoptosis, necrosis, and living cells over time.
  • Optimal Concentration and Survival: Cell viability peaked at a visfatin concentration of 200 ng/mL. The most striking insight is that endogenous visfatin acts as a "safety net." When researchers inhibited visfatin in mice treated with LPS, the inflammatory response became lethal, leading to rapid mortality. This suggests visfatin is essential for tempering immune overreaction.
  • Apoptosis Inhibition: In RAW264.7 cells, exogenous visfatin significantly reduced late-stage apoptosis caused by LPS. This was achieved by regulating the Bcl-2 family of genes, promoting anti-apoptotic genes (Bcl2l1, Bcl2a1a) while suppressing pro-apoptotic signals (Fas, Caspase 3, Bax).
  • Pathway Integration: Visfatin exhibits a "dual effect" on inflammation, modulating pathways like MAPK and Rap1. To inhibit apoptosis, it recruits the PI3K/AKT and Hippo signaling pathways, essentially signaling macrophages to remain viable during inflammatory challenges.

Datasets

The primary dataset generated is the transcriptomic profile of RAW264.7 cells under various treatments.

  • RNA-seq Data: Available via the NCBI Short Read Archive (SRA) under accession number PRJNA293603.
  • The study identified 1,225 differentially expressed genes (DEGs), providing a significant resource for researchers studying macrophage activation.

Discussion and Future Directions

While providing a robust map of visfatin’s regulatory network, some gaps remain. The in vitro work focused exclusively on the RAW264.7 macrophage line; future studies should explore if visfatin plays a similar protective role in T or B lymphocytes. Additionally, while signaling pathways like PI3K/AKT were identified, the exact receptor triggering these signals remains to be fully characterized.

Clinically, the finding that visfatin inhibition leads to rapid death in inflammatory models suggests that drugs targeting NAMPT (often researched for cancer) must be evaluated carefully for their impact on a patient's underlying immune stability.

Summary updated

Abstract

Visfatin, a multifunctional adipocytokine, is particularly important in the regulation of apoptosis and inflammation through an unidentified mechanism. Clarifying the control mechanisms of visfatin on inflammation and apoptosis in RAW264.7 cells and mice immunological organs was the goal of the current investigation. In order to create a pathophysiological model, the RAW264.7 cells were stimulated with 200 ng/mL visfatin and 20 μg/mL lipopolysaccharide (LPS), either separately or combined. The effects of exogenous visfatin on inflammation and apoptosis in RAW264.7 cells were investigated by flow cytometry assay, RNA-seq analysis and fluorescence quantitative PCR. According to the findings, exogenous visfatin exhibits dual effects on inflammation by modulating the expression of IL-1α, TNFRSF1B, and LIF as well as taking part in various signaling pathways, including the MAPK and Rap1 signaling pathways. By controlling the expression levels of Bcl2l1, Bcl2a1a, and Fas and primarily participating in the PI3K/AKT signaling pathway and Hippo signaling pathway, exogenous visfatin can inhibit apoptosis in RAW264.7 cells. The visfatin inhibitor FK866 was used to further confirm the effects of visfatin on inflammation and apoptosis in mice immune organs. Subsequently, mice spleen and thymus were collected. It is interesting to note that in LPS-treated mice, suppression of endogenous visfatin might worsen the immune system's inflammatory response and even result in rapid mortality. Additionally, endogenous visfatin promotes the apoptosis in mice immune organs by regulating the expression levels of Bcl2l1, Fas, Caspase 3, Bcl2a1a, and Bax. Together, these results imply that visfatin is a multifaceted molecule that regulates inflammation and apoptosis in RAW264.7 cells and mice immunological organs by taking part in a variety of biological processes and regulating the amounts of associated cytokines expression. Our findings offer additional understandings of how visfatin affects apoptosis and inflammation.
BibTeX
@inproceedings{zhang2022visfatin,
  author = {Zhewei Zhang and Ke Xiao and Sheng Wang and Abdur Rahman Ansari and Xiaoyu Niu and Wenjie Yang and Mengqi Lu and Zhi Yang and Zia Ur Rehman and Weihua Zou and Weicheng Bei and Hui Song},
  title = {{Visfatin is a multifaceted molecule that exerts regulation effects on inflammation and apoptosis in RAW264.7 cells and mice immune organs}},
  booktitle = {Frontiers in Immunology},
  year = {2022},
  doi = {10.3389/fimmu.2022.1018973},
}
Figure